VPTDF (VentriPoint Diagnostics) FCF Margin %: -14,466.67% (As of Dec. 2025)


VPTDF VentriPoint Diagnostics Ltd VPTDF
6 GF Score
Price $0.08
! 4 Warning Signs
View Full Analysis

What is VentriPoint Diagnostics FCF Margin %?

VentriPoint Diagnostics VPTDF 6 FCF Margin % is -14,466.67% as of Dec. 2025. GuruFocus rates VPTDF with a GF Score™ of 6/100. The stock has 4 warning signs investors should review. Among 815 Medical Devices & Instruments companies, VentriPoint Diagnostics ranks worse than 94.36% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. VentriPoint Diagnostics's Free Cash Flow for the three months ended in Dec. 2025 was $-0.43 Mil. VentriPoint Diagnostics's Revenue for the three months ended in Dec. 2025 was $0.00 Mil. Therefore, VentriPoint Diagnostics's FCF Margin % for the quarter that ended in Dec. 2025 was -14,466.67%.

As of today, VentriPoint Diagnostics's current FCF Yield % is -8.10%.

The historical rank and industry rank for VentriPoint Diagnostics's FCF Margin % or its related term are showing as below:

VPTDF' s FCF Margin % Range Over the Past 10 Years
Min: -7971.79   Med: -3564.21   Max: -863.89
Current: -882.68

During the past 13 years, the highest FCF Margin % of VentriPoint Diagnostics was -863.89%. The lowest was -7971.79%. And the median was -3564.21%.

VPTDF's FCF Margin % is ranked worse than
94.36% of 815 companies
in the Medical Devices & Instruments industry
Industry Median: -0.03 vs VPTDF: -882.68

VentriPoint Diagnostics FCF Margin % Related Terms

VentriPoint Diagnostics FCF Margin % Historical Data

* Premium members only.

The historical data trend for VentriPoint Diagnostics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

VentriPoint Diagnostics FCF Margin % Chart

VentriPoint Diagnostics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -6,090.00 -7,662.16 -3,547.76 -866.92

VentriPoint Diagnostics Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -444.90 0.00 -92.00 -14,466.67

VPTDF vs ABT, SYK, MDT: FCF Margin % Comparison

For the Medical Devices subindustry, VentriPoint Diagnostics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

VentriPoint Diagnostics FCF Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, VentriPoint Diagnostics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where VentriPoint Diagnostics's FCF Margin % falls into.


VPTDF
6GF Score
VentriPoint Diagnostics Ltd VPTDF
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

VentriPoint Diagnostics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

VentriPoint Diagnostics's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-1.127/0.13
=-866.92 %

VentriPoint Diagnostics's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-0.434/0.003
=-14,466.67 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -14,466.67% mean?
VentriPoint Diagnostics (VPTDF) has a FCF Margin % of -14,466.67% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on VentriPoint Diagnostics and its competitors. According to the industry distribution chart, VentriPoint Diagnostics ranks #769 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 94.4%.
Is VentriPoint Diagnostics' FCF Margin % too high?
VentriPoint Diagnostics' current FCF Margin % is -14,466.67%. Based on the distribution chart, VentriPoint Diagnostics ranks #769 out of 815 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, VentriPoint Diagnostics has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does VentriPoint Diagnostics' FCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, VentriPoint Diagnostics ranks #769 out of 815 companies for FCF Margin %. This places VentriPoint Diagnostics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on VentriPoint Diagnostics and its competitors. VentriPoint Diagnostics's current FCF Margin % is -14,466.67%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is VentriPoint Diagnostics stock overvalued right now?
VentriPoint Diagnostics (VPTDF) has a current FCF Margin % of -14,466.67%. The current FCF Margin % is -14,466.67%. VentriPoint Diagnostics' overall GF Score™ is 6/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For VentriPoint Diagnostics (VPTDF), the current FCF Margin % is -14,466.67% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

VentriPoint Diagnostics Business Description

Other Exchanges VPT:Canada
Address 18 Hook Avenue, Unit 101, Toronto, ON, CAN, M6P 1T4
VentriPoint Diagnostics Ltd is a medical device company engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. Its flagship product, the Ventripoint Medical System (VMS+), transforms standard 2D and 3D echocardiography and MRI images into accurate three-dimensional heart models and volumetric measurements, enabling clinicians to assess disease severity, track progression, evaluate treatment response, and guide surgical and pharmacological decisions. Additionally, the company has developed VMS+ 3D Echo and MRI software that can be installed on any personal workstation to create a 3D model of the heart's chamber. Geographically, its products are sold in Canada and internationally.
6GF Score

Get the complete analysis for VPTDF

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.08
Price